FDA Inspection 791266 — Matthew G. Davis, M.D.

Matthew G. Davis, M.D. — FEI 3007220553

The FDA completed an inspection of Matthew G. Davis, M.D. on July 16, 2012 in Rochester, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 16, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Rochester, NY (United States)

Additional Details

Clinical Investigator (CI)